A medicine that was being developed for cancer has shown potential in modulating the immune response to prevent the deadly cytokine storm. Researchers call it a breakthrough as 29 of 30 phase 1 trial patients left hospital within 3-5 days.
Tel Aviv’s Ichilov Medical Center has successfully completed the phase 1 trials for a new drug that appears to have helped numerous moderate-to-serious cases to quickly recover from COVID-19. The hospital calls it a huge breakthrough as all 30 patients suffering from moderate to severe Covid-19, who received the drug recovered — 29 of them within three to five days.
EXO-CD24 -a targeted drug that was being developed as a cure for cancer for the past few years, makes use of tiny carrier sacs knows as exosomes to deliver a protein called CD24 to the lungs. The drug fights the cytokine storm, which is an overreaction to the SARS-CoV-2 infection by the immune system that is believed to be potentially lethal.
The drug EXO-CD24 is different from other molecules in that it is directly inhaled into the lungs, which happen to be the epicentres of the cytokine storm. It is to be inhaled once a day for a few minutes, for five days.
Tags:
Rapid Antigen Test (RAT) showed an excellent specificity to 'rule-in' COVID-19 patients within the first 5 days of illness and had a moderate sensitivity. ...
PHILADELPHIA, U.S.: Some young children experience severe dental caries that resists normal therapies. According to a recent study carried out by ...
TRIESTE, Italy: The majority of COVID-19 patients self-report olfactory and gustatory disfunction, making these among the most common symptoms of the ...
Dubai, UAE: A survey of residents in the UAE and Saudi Arabia has found that 88% of the respondents appreciate the advantages of teledentistry and online ...
With newer variants emerging and challenging our previously acquired immunity and creating worldwide uncertainty, there is an urgent need for antiviral ...
BIRMINGHAM, UK: To fill a research gap, researchers have recently examined whether dental professionals are, in fact, at an increased risk of becoming ...
LEIPZIG, Germany: Given that little time has passed since the outbreak of SARS-CoV-2, it comes as no surprise that only sparse data on COVID-19 is available...
Sandeep Chakraborty (B-Tech, Electrical Engineering IIT Kharagpur, 1997), (Masters. Computer science, IIT Kharagpur, 2008) is a researcher focused on ...
The US Food and Drug Administration has granted 'Emergency Use Authorization (EUA)' for Gilead Sciences’ antiviral drug remdesivir to treat COVID-19, the ...
Live webinar
Thu. 11 September 2025
10:30 pm IST (New Delhi)
Live webinar
Mon. 15 September 2025
10:30 pm IST (New Delhi)
Prof. Dr. med. dent. Stefan Wolfart
Live webinar
Tue. 16 September 2025
8:30 pm IST (New Delhi)
Prof. Dr. Dr. Florian Guy Draenert
Live webinar
Tue. 16 September 2025
10:00 pm IST (New Delhi)
Dr. Kay Vietor, Birgit Sayn
Live webinar
Tue. 16 September 2025
10:30 pm IST (New Delhi)
Dr. Paweł Aleksandrowicz PhD
Live webinar
Wed. 17 September 2025
5:30 am IST (New Delhi)
Live webinar
Wed. 17 September 2025
4:00 pm IST (New Delhi)
International / International
Brazil / Brasil
Canada / Canada
Latin America / Latinoamérica
USA / USA
Austria / Österreich
Bosnia and Herzegovina / Босна и Херцеговина
Bulgaria / България
Croatia / Hrvatska
Czech Republic & Slovakia / Česká republika & Slovensko
France / France
Germany / Deutschland
Greece / ΕΛΛΑΔΑ
Hungary / Hungary
Italy / Italia
Netherlands / Nederland
Nordic / Nordic
Poland / Polska
Portugal / Portugal
Romania & Moldova / România & Moldova
Slovenia / Slovenija
Serbia & Montenegro / Србија и Црна Гора
Spain / España
Switzerland / Schweiz
Turkey / Türkiye
UK & Ireland / UK & Ireland
China / 中国
Japan / 日本
Pakistan / Pākistān
Vietnam / Việt Nam
ASEAN / ASEAN
Israel / מְדִינַת יִשְׂרָאֵל
Algeria, Morocco & Tunisia / الجزائر والمغرب وتونس
Middle East / Middle East
Dr. Jenny Apekian DDSRegister now1CELive webinar
Prof. Dr. med. dent. Stefan WolfartRegister now1CELive webinar
Dr. Paweł Aleksandrowicz PhDRegister now1CELive webinar
Dr. Ashton Prince DMDRegister now1CE:sharpen(level=0):output(format=png)/up/dt/2022/01/Ivoclar_Logo_19-01-2022.png "Ivoclar")
:sharpen(level=0):output(format=webp)/up/dt/2025/09/US-H1B-wage-based-work-permi.jpg "Why the new US H1B wage-based work permit is a game-changer for international dentists")
:sharpen(level=0):output(format=webp)/up/dt/2025/08/enamel-regeneration.jpg "Breakthrough: Keratin toothpaste can make enamel regeneration possible soon")
:sharpen(level=0):output(format=webp)/up/dt/2025/08/mental-health-dentists.jpg "Rising mental health challenges in dentistry: a silent burden dentists carry")
:sharpen(level=0):output(format=webp)/up/dt/2025/08/Vasa-Dentcity-Dentalkart.jpg "Vasa Denticity Ltd. acquires 51% stake in IDS Denmed Pvt. Ltd., creating India’s largest integrated dental supply network")
:sharpen(level=0):output(format=webp)/up/dt/2025/08/Laxmi-dental.jpg "Laxmi Dental to acquire majority stake in AI Dent, to expand AI capabilities in digital dentistry")
:sharpen(level=0):output(format=webp)/up/dt/2025/07/3dprinting.jpg "3D printing")
:sharpen(level=0):output(format=webp)/up/dt/2025/07/aligners.jpg "aligners")
:sharpen(level=0):output(format=webp)/up/dt/2022/01/Ivoclar_Logo_19-01-2022.png "Ivoclar"){kind=logo}
:sharpen(level=0):output(format=webp)/up/dt/2019/04/logo.png "exocad"){kind=logo}
:sharpen(level=0):output(format=webp)/up/dt/2022/05/osstem_logo.png "Osstem Implant"){kind=logo}
:sharpen(level=0):output(format=webp)/up/dt/2025/01/DMP-Logo-2025.png "DMP DENTAL INDUSTRY"){kind=logo}
:sharpen(level=0):output(format=webp)/up/dt/2024/05/Curaden_Logo_RGB1.png "Curaden"){kind=logo}
:sharpen(level=0):output(format=webp)/up/dt/2011/11/ITI-LOGO.png "ITI International Team for Implantology"){kind=logo}
:sharpen(level=0):output(format=webp)/up/dt/e-papers/358659/1.jpg "DT South Asia No. 3, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/357919/1.jpg "DT South Asia No. 2, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/357405/1.jpg "DT South Asia No. 1, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/357205/1.jpg "DT South Asia No. 6, 2024")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/348833/1.jpg "DT South Asia No. 5, 2024")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/347072/1.jpg "DT South Asia No. 4, 2024")
:sharpen(level=0):output(format=webp)/up/dt/2021/02/Copy-of-780-x-439-DT-11.jpg "Israeli hospital claims new drug 'cured' 29 of 30 moderate to severe Covid patients in days")
:sharpen(level=0):output(format=webp)/up/dt/2025/09/US-H1B-wage-based-work-permi.jpg "Why the new US H1B wage-based work permit is a game-changer for international dentists")
:sharpen(level=0):output(format=webp)/wp-content/themes/dt/images/no-user.gif "Rajeev Chitguppi, Dental Tribune South Asia")
:sharpen(level=0):output(format=webp)/up/dt/2020/11/Copy-of-780-x-439-DT-3.jpg "New ICMR study: Rapid Antigen Test can detect COVID-19 patients within the first 5 days of illness")
:sharpen(level=0):output(format=webp)/up/dt/2018/05/2018_05_02-synergy-of-microorganisms-shutterstock_618699125-780x439.jpg "Resistance to anti-fungal drugs increased seen in severe childhood dental caries")
:sharpen(level=0):output(format=webp)/up/dt/2022/01/Is-loss-of-taste-overestimated-among-COVID-19-patients.jpg "Is loss of taste overestimated among COVID-19 patients?")
:sharpen(level=0):output(format=webp)/up/dt/2022/01/COVID-19-advances-acceptance-of-teledentistry-among-patients.jpg "COVID-19 advances acceptance of teledentistry among patients")
:sharpen(level=0):output(format=webp)/up/dt/2021/12/Copy-of-780-x-439-DT-4.jpg "New molecule to block COVID-19 infection")
:sharpen(level=0):output(format=webp)/up/dt/2021/06/New-study-examines-extent-of-occupational-risk-of-COVID-19-in-UK.jpg "New study examines extent of occupational risk of COVID-19 in UK")
:sharpen(level=0):output(format=webp)/up/dt/2020/05/Good-oral-health-may-prevent-severe-COVID-19-progression..jpg "Good oral health may prevent severe COVID-19 progression")
:sharpen(level=0):output(format=webp)/up/dt/2020/05/780-x-439-DT-25.jpg "Severe form of COVID 19: Mainly a vascular disease? Can 'Anaerobic Bacteria Hypothesis' explain it?")
:sharpen(level=0):output(format=webp)/up/dt/2020/05/780-x-439-DT-23.jpg "US FDA grants Emergency Use Authorization (EUA) for the antiviral drug Remdesivir to treat COVID-19")
:sharpen(level=0):output(format=webp)/up/dt/2025/09/US-H1B-wage-based-work-permi.jpg "Why the new US H1B wage-based work permit is a game-changer for international dentists")
:sharpen(level=0):output(format=webp)/up/dt/2025/08/enamel-regeneration.jpg "Breakthrough: Keratin toothpaste can make enamel regeneration possible soon")
:sharpen(level=0):output(format=webp)/up/dt/2025/08/mental-health-dentists.jpg "Rising mental health challenges in dentistry: a silent burden dentists carry")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/357919/1.jpg "DT South Asia No. 2, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/357405/1.jpg "DT South Asia No. 1, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/357205/1.jpg "DT South Asia No. 6, 2024")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/348833/1.jpg "DT South Asia No. 5, 2024")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/347072/1.jpg "DT South Asia No. 4, 2024")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/358659/1.jpg "DT South Asia No. 3, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/358659/2.jpg "ISSUE")
To post a reply please login or register